Ultomiris (ravulizumab)

pCPA File Number: 21780
Negotiation Status:
Concluded with an LOI
Indication(s):
Paroxysmal nocturnal hemoglobinuria (PNH)
Sponsor/Manufacturer:
Alexion Pharma GmbH
CDA-AMC Project Number:
SR0700-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: